Revenue breakdown by Products & Services
Revenue breakdown by Geography

Johnson & Johnson's Revenue by Segment

In fiscal year 2025, Johnson & Johnson's revenue by segment (products & services) are as follows:

  • Innovative Medicine: $60.40 B
  • MedTech: $33.79 B

Learn more about Johnson & Johnson’s Revenue by Geography

Check out competitors to Johnson & Johnson in a side-by-side comparison.

Explore additional financial metrics for Johnson & Johnson.

Continue reading...

The above chart shows Johnson & Johnson's revenue percentage share by segment (products and services).

In fiscal year 2023, Johnson & Johnson's revenue by segment is as follows:

  • Innovative Medicine generated $54.76 B in revenue, representing 64.3% of its total revenue.
  • MedTech generated $30.40 B in revenue, representing 35.7% of its total revenue.

The biggest segment for Johnson & Johnson is the Innovative Medicine, which represents 64.3% of its total revenue.
The smallest segment for Johnson & Johnson is the MedTech, which represents 35.7% of its total revenue.

The above chart shows Johnson & Johnson's revenue percentage share by segment (products and services).

In fiscal year 2024, Johnson & Johnson's revenue by segment is as follows:

  • Innovative Medicine generated $56.96 B in revenue, representing 64.13% of its total revenue.
  • MedTech generated $31.86 B in revenue, representing 35.87% of its total revenue.

The biggest segment for Johnson & Johnson is the Innovative Medicine, which represents 64.13% of its total revenue.
The smallest segment for Johnson & Johnson is the MedTech, which represents 35.87% of its total revenue.

The above chart shows Johnson & Johnson's revenue percentage share by segment (products and services).

In fiscal year 2025, Johnson & Johnson's revenue by segment is as follows:

  • Innovative Medicine generated $60.40 B in revenue, representing 64.12% of its total revenue.
  • MedTech generated $33.79 B in revenue, representing 35.88% of its total revenue.

The biggest segment for Johnson & Johnson is the Innovative Medicine, which represents 64.12% of its total revenue.
The smallest segment for Johnson & Johnson is the MedTech, which represents 35.88% of its total revenue.
Continue reading...

Summary Table

Products & Services (Percent Share) 2023 2024 2025
Innovative Medicine 64.3% 64.13% 64.12%
MedTech 35.7% 35.87% 35.88%
Total Revenue 100% 100% 100%

The above chart shows the revenue trend of different segments of Johnson & Johnson.

In fiscal year 2025, the Innovative Medicine generated the most revenue ($60.40 B), and the MedTech generated the least revenue ($33.79 B).

The above chart shows growth drivers and a year-over-year comparison of different segments' revenue.

  • Innovative Medicine revenue increased 6.03% ($3.44 B) from $56.96 B (in 2024) to $60.40 B (in 2025).
  • MedTech revenue increased 6.07% ($1.94 B) from $31.86 B (in 2024) to $33.79 B (in 2025).
  • Continue reading...

    Summary Table

    Products & Services 2023 2024 2025
    Innovative Medicine $54.76 B - $56.96 B
    4.03%
    $60.40 B
    6.03%
    MedTech $30.40 B - $31.86 B
    4.79%
    $33.79 B
    6.07%
    Total Revenue $85.16 B - $88.82 B
    4.30%
    $94.19 B
    6.05%